Skip to content
Constant Therapeutics

About Constant Therapeutics

Constant Therapeutics LLC is a clinical stage company developing Mas receptor agonists for treatment of COVID-19, CNS, and rare disorders. It’s lead clinical programs are in COVID-19, chronic stroke recovery, epidermolysis bullosa and cardiomyopathy associated with Duchenne Muscular Dystrophy. Constant was recently formed by combining the assets of TarixCVM LLC and Tarix Orphan LLC.

Comments are closed.